Arrowhead Pharmaceuticals Inc.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2003 | — | — | $-95.2K |
| FY2004 | — | — | $-751.3K |
| FY2005 | — | — | $-6.7M |
| FY2006 | — | — | $-20.0M |
| FY2007 | — | — | $-30.7M |
| FY2008 | — | — | $-27.2M |
| FY2009 | — | — | $-19.3M |
| FY2010 | — | $-5.8M | $-5.8M |
| FY2011 | $296.1K | $-9.8M | $-3.1M |
| FY2012 | $146.9K | $-21.1M | $-21.1M |
| FY2013 | $290.3K | $-24.6M | $-31.1M |
| FY2014 | $175.0K | $-53.3M | $-58.6M |
| FY2015 | $382.0K | $-96.0M | $-91.9M |
| FY2016 | $158.3K | $-81.7M | $-81.7M |
| FY2017 | $31.4M | $-37.0M | $-34.4M |
| FY2018 | $16.1M | $-55.9M | $-54.5M |
| FY2019 | $168.8M | $61.2M | $68.0M |
| FY2020 | $88.0M | $-93.2M | $-84.6M |
| FY2021 | $138.3M | $-149.0M | $-140.8M |
| FY2022 | $243.2M | $-178.5M | $-176.1M |
| FY2023 | $240.7M | $-205.0M | $-205.3M |
| FY2024 | $3.6M | $-601.1M | $-599.5M |
| FY2025 | $829.4M | $98.3M | $-1.6M |